Follicular Lymphoma (FL)

Also known as: Follicular lymphoma / Lymphoma, Follicular / Follicular Lymphomas / Lymphomas, Follicular / Nodular lymphoma / Nodular (follicular) lymphoma

DrugDrug NameDrug Description
DB13915Axicabtagene ciloleucelAxicabtagene ciloleucel is a chimeric antigen receptor (CAR) T cell therapy for the treatment of Diffuse large B-cell lymphoma (DLBCL), which is a type of a non-Hodgkin lymphoma (NHL). It is the second cell-based gene therapy that is FDA-approved but the first in the treatment of large B-cell lymphoma in adult patients. Uniquely, axicabtagene ciloleucel utilizes each patient’s own immune system where each dose of the drug consists of the patient's genetically modified T-cells that were previously collected. The modified version of the T-cell expresses a new gene that targets and kills the lymphoma cells and is infused back into the patient. Diffuse large B-cell lymphoma (DLBCL) is the most common type of NHL in adults that mostly originates from the lymph nodes but can initiate outside of the lymphatic system. Lymphoma cells appear to be much larger in size than normal lymphocytes. In a multicenter clinical trial, the patients who were treated with axicabtagene ciloleucel achieved the complete remission rate of 51%. Developed by Kite Pharma, Inc., it was approved on October 18th, 2017 by the FDA as an intravenously infused anticancer therapy and is marketed under the brand name Yescarta.
DB00070HyaluronidaseHighly purified sheep hyaluronidase for administration by injection into the vitreous of the eye.
DrugDrug NamePhaseStatusCount
DB09053Ibrutinib0Recruiting1
DB00811Ribavirin0Recruiting1
DB05220Alisertib1Terminated1
DB06467Apolizumab1Terminated1
DB11945Avelumab1Not Yet Recruiting1
DB00928Azacitidine1Active Not Recruiting1
DB05015Belinostat1Completed1
DB06769Bendamustine1Completed1
DB06769Bendamustine1Recruiting1
DB11666Buparlisib1Active Not Recruiting1
DB08889Carfilzomib1Completed1
DB00531Cyclophosphamide1Active Not Recruiting1
DB00531Cyclophosphamide1Recruiting1
DB00531Cyclophosphamide1Terminated2
DB11731Depatuxizumab mafodotin1Completed1
DB12021Dinaciclib1Recruiting1
DB00997Doxorubicin1Recruiting1
DB00997Doxorubicin1Terminated1
DB00773Etoposide1Terminated1
DB09053Ibrutinib1Active Not Recruiting1
DB09053Ibrutinib1Withdrawn1
DB09054Idelalisib1Completed2
DB09054Idelalisib1Recruiting1
DB10791Influenza A virus A/california/7/2009 x-179a (H1N1) antigen (formaldehyde inactivated)1Recruiting1
DB00480Lenalidomide1Active Not Recruiting1
DB06360Lucatumumab1Completed1
DB09035Nivolumab1Not Yet Recruiting1
DB09035Nivolumab1Recruiting1
DB08935Obinutuzumab1Recruiting2
DB06650Ofatumumab1Completed1
DB09037Pembrolizumab1Active Not Recruiting1
DB09037Pembrolizumab1Recruiting2
DB00860Prednisolone1Terminated1
DB00635Prednisone1Active Not Recruiting1
DB00635Prednisone1Recruiting1
DB00635Prednisone1Terminated1
DB00073Rituximab1Active Not Recruiting2
DB00073Rituximab1Completed3
DB00073Rituximab1Not Yet Recruiting3
DB00073Rituximab1Recruiting4
DB00073Rituximab1Terminated2
DB00020Sargramostim1Completed1
DB12887Tazemetostat1Recruiting1
DB06273Tocilizumab1Recruiting1
DB00081Tositumomab1Completed1
DB09557Tositumomab1Completed1
DB11581Venetoclax1Recruiting2
DB00541Vincristine1Active Not Recruiting1
DB00541Vincristine1Recruiting2
DB00541Vincristine1Terminated2
DB06361rsPSMA Vaccine1Active Not Recruiting1
DB11703Acalabrutinib1 / 2Recruiting1
DB09312Antilymphocyte immunoglobulin (horse)1 / 2Not Yet Recruiting1
DB00098Antithymocyte immunoglobulin (rabbit)1 / 2Not Yet Recruiting1
DB06769Bendamustine1 / 2Recruiting1
DB00188Bortezomib1 / 2Completed1
DB00493Cefotaxime1 / 2Not Yet Recruiting1
DB00631Clofarabine1 / 2Completed1
DB06189Clofarabine1 / 2Completed1
DB00531Cyclophosphamide1 / 2Completed1
DB00531Cyclophosphamide1 / 2Not Yet Recruiting1
DB00531Cyclophosphamide1 / 2Recruiting1
DB00531Cyclophosphamide1 / 2Withdrawn1
DB00997Doxorubicin1 / 2Completed1
DB11714Durvalumab1 / 2Active Not Recruiting1
DB11714Durvalumab1 / 2Recruiting1
DB01073Fludarabine1 / 2Not Yet Recruiting1
DB01073Fludarabine1 / 2Withdrawn1
DB00441Gemcitabine1 / 2Recruiting1
DB09053Ibrutinib1 / 2Active Not Recruiting1
DB12325Idasanutlin1 / 2Recruiting1
DB09054Idelalisib1 / 2Completed1
DB00480Lenalidomide1 / 2Active Not Recruiting1
DB00480Lenalidomide1 / 2Completed1
DB00480Lenalidomide1 / 2Withdrawn1
DB01042Melphalan1 / 2Recruiting1
DB05764Navitoclax1 / 2Completed1
DB08935Obinutuzumab1 / 2Active Not Recruiting2
DB08935Obinutuzumab1 / 2Recruiting1
DB06650Ofatumumab1 / 2Withdrawn1
DB09037Pembrolizumab1 / 2Recruiting1
DB12240Polatuzumab Vedotin1 / 2Active Not Recruiting1
DB00635Prednisone1 / 2Completed1
DB00073Rituximab1 / 2Active Not Recruiting1
DB00073Rituximab1 / 2Completed2
DB00073Rituximab1 / 2Recruiting2
DB06287Temsirolimus1 / 2Completed1
DB12227Tetulomab tetraxetan Lu-1771 / 2Recruiting1
DB05656Veltuzumab1 / 2Completed1
DB05656Veltuzumab1 / 2Terminated1
DB11581Venetoclax1 / 2Recruiting1
DB00541Vincristine1 / 2Completed1
DB12565Abexinostat2Recruiting1
DB11780Allicin2Unknown Status1
DB00437Allopurinol2Recruiting1
DB09312Antilymphocyte immunoglobulin (horse)2Terminated1
DB00098Antithymocyte immunoglobulin (rabbit)2Terminated1
DB11595Atezolizumab2Recruiting1
DB13915Axicabtagene ciloleucel2Recruiting1
DB00928Azacitidine2Terminated1
DB06769Bendamustine2Active Not Recruiting1
DB06769Bendamustine2Completed4
DB06769Bendamustine2Recruiting1
DB06769Bendamustine2Terminated2
DB06769Bendamustine2Withdrawn1
DB00112Bevacizumab2Completed1
DB00188Bortezomib2Active Not Recruiting1
DB00188Bortezomib2Completed4
DB00188Bortezomib2Terminated5
DB08870Brentuximab vedotin2Withdrawn1
DB01008Busulfan2Recruiting1
DB00262Carmustine2Active Not Recruiting1
DB00493Cefotaxime2Recruiting1
DB00531Cyclophosphamide2Completed3
DB00531Cyclophosphamide2Recruiting3
DB00987Cytarabine2Active Not Recruiting1
DB00987Cytarabine2Recruiting1
DB09331Daratumumab2Terminated1
DB01234Dexamethasone2Active Not Recruiting1
DB01234Dexamethasone2Terminated1
DB00997Doxorubicin2Completed1
DB00254Doxycycline2Terminated1
DB08846Ellagic Acid2Unknown Status1
DB06210Eltrombopag2Terminated1
DB12121Entospletinib2Active Not Recruiting1
DB06486Enzastaurin2Completed1
DB00773Etoposide2Active Not Recruiting1
DB00773Etoposide2Recruiting1
DB01073Fludarabine2Completed2
DB01073Fludarabine2Recruiting3
DB01073Fludarabine2Terminated2
DB00078Ibritumomab tiuxetan2Completed2
DB00078Ibritumomab tiuxetan2Unknown Status2
DB09053Ibrutinib2Active Not Recruiting1
DB09053Ibrutinib2Completed1
DB09053Ibrutinib2Enrolling by Invitation1
DB09053Ibrutinib2Recruiting1
DB09054Idelalisib2Completed1
DB09054Idelalisib2Recruiting1
DB09054Idelalisib2Terminated1
DB05003Imexon2Completed1
DB09284Imolamine2Unknown Status1
DB05707Isosorbide2Completed2
DB09570Ixazomib2Completed1
DB09570Ixazomib2Recruiting1
DB00125L-Arginine2Completed1
DB00480Lenalidomide2Active Not Recruiting2
DB00480Lenalidomide2Completed1
DB00480Lenalidomide2Recruiting1
DB00480Lenalidomide2Terminated1
DB04835Maraviroc2Completed1
DB01042Melphalan2Active Not Recruiting1
DB01042Melphalan2Recruiting2
DB00563Methotrexate2Completed1
DB00563Methotrexate2Terminated1
DB01204Mitoxantrone2Completed2
DB01204Mitoxantrone2Terminated2
DB00688Mycophenolate mofetil2Completed1
DB00688Mycophenolate mofetil2Recruiting3
DB12191Obatoclax2Completed1
DB08935Obinutuzumab2Recruiting2
DB06650Ofatumumab2Completed3
DB06650Ofatumumab2Withdrawn1
DB11133Omega-3 fatty acids2Unknown Status1
DB09037Pembrolizumab2Recruiting2
DB04216Quercetin2Unknown Status1
DB02709Resveratrol2Unknown Status1
DB00073Rituximab2Active Not Recruiting4
DB00073Rituximab2Completed14
DB00073Rituximab2Recruiting4
DB00073Rituximab2Terminated7
DB00073Rituximab2Unknown Status2
DB00073Rituximab2Withdrawn1
DB00020Sargramostim2Recruiting1
DB00020Sargramostim2Terminated1
DB11127Selenious acid2Unknown Status1
DB11135Selenium2Unknown Status1
DB00877Sirolimus2Recruiting1
DB09325Sodium fluoride2Recruiting1
DB00864Tacrolimus2Completed1
DB00864Tacrolimus2Recruiting2
DB00864Tacrolimus2Terminated1
DB12887Tazemetostat2Recruiting1
DB13881Tisagenlecleucel2Not Yet Recruiting1
DB00081Tositumomab2Completed1
DB00081Tositumomab2Terminated2
DB09557Tositumomab2Terminated1
DB02891Tricyclazole2Recruiting1
DB11581Venetoclax2Completed1
DB11581Venetoclax2Recruiting2
DB00541Vincristine2Completed1
DB02546Vorinostat2Active Not Recruiting1
DB02546Vorinostat2Terminated1
DB06769Bendamustine2 / 3Recruiting1
DB00531Cyclophosphamide2 / 3Terminated1
DB00099Filgrastim2 / 3Terminated1
DB01073Fludarabine2 / 3Terminated1
DB00563Methotrexate2 / 3Terminated1
DB00073Rituximab2 / 3Terminated1
DB00864Tacrolimus2 / 3Terminated1
DB11850Ublituximab2 / 3Recruiting1
DB09495Avobenzone3Recruiting1
DB06769Bendamustine3Active Not Recruiting1
DB06769Bendamustine3Completed1
DB06769Bendamustine3Recruiting1
DB06769Bendamustine3Withdrawn1
DB00002Cetuximab3Active Not Recruiting1
DB00531Cyclophosphamide3Active Not Recruiting2
DB00531Cyclophosphamide3Recruiting1
DB00531Cyclophosphamide3Terminated1
DB00531Cyclophosphamide3Unknown Status1
DB01234Dexamethasone3Terminated1
DB00997Doxorubicin3Active Not Recruiting1
DB00997Doxorubicin3Recruiting1
DB11952Duvelisib3Terminated1
DB11952Duvelisib3Withdrawn1
DB01073Fludarabine3Completed1
DB01073Fludarabine3Terminated1
DB01073Fludarabine3Unknown Status1
DB11064Homosalate3Recruiting1
DB00078Ibritumomab tiuxetan3Terminated1
DB00078Ibritumomab tiuxetan3Withdrawn1
DB09053Ibrutinib3Enrolling by Invitation1
DB09053Ibrutinib3Recruiting1
DB09054Idelalisib3Recruiting1
DB05889Inotuzumab ozogamicin3Terminated1
DB00125L-Arginine3Active Not Recruiting1
DB00125L-Arginine3Recruiting1
DB00480Lenalidomide3Active Not Recruiting2
DB00480Lenalidomide3Recruiting1
DB01204Mitoxantrone3Terminated1
DB09496Octinoxate3Recruiting1
DB09535Octocrylene3Recruiting1
DB06650Ofatumumab3Active Not Recruiting1
DB06193Pixantrone3Terminated1
DB00860Prednisolone3Active Not Recruiting1
DB00860Prednisolone3Terminated1
DB00860Prednisolone3Unknown Status1
DB00635Prednisone3Active Not Recruiting1
DB00635Prednisone3Recruiting1
DB00635Prednisone3Terminated1
DB00073Rituximab3Active Not Recruiting7
DB00073Rituximab3Completed5
DB00073Rituximab3Recruiting6
DB00073Rituximab3Terminated4
DB00073Rituximab3Unknown Status2
DB00073Rituximab3Withdrawn1
DB09557Tositumomab3Withdrawn1
DB00541Vincristine3Active Not Recruiting2
DB00541Vincristine3Recruiting1
DB00541Vincristine3Terminated1
DB00541Vincristine3Unknown Status1
DB00188BortezomibNot AvailableTerminated1
DB00531CyclophosphamideNot AvailableRecruiting1
DB00531CyclophosphamideNot AvailableTerminated1
DB00091CyclosporineNot AvailableRecruiting1
DB01073FludarabineNot AvailableRecruiting1
DB00078Ibritumomab tiuxetanNot AvailableCompleted1
DB00688Mycophenolate mofetilNot AvailableRecruiting1
DB08935ObinutuzumabNot AvailableRecruiting1
DB00635PrednisoneNot AvailableTerminated1
DB00073RituximabNot AvailableCompleted4
DB00073RituximabNot AvailableTerminated1